INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 103 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $125,632,000 | -20.4% | 20,800 | +26.8% | 0.00% | – |
| Q4 2017 | $157,768,000 | +8.3% | 16,400 | 0.0% | 0.00% | – |
| Q3 2017 | $145,632,000 | -29.8% | 16,400 | 0.0% | 0.00% | – |
| Q2 2017 | $207,460,000 | +20.4% | 16,400 | 0.0% | 0.00% | – |
| Q1 2017 | $172,364,000 | +81978.1% | 16,400 | -7.9% | 0.00% | – |
| Q3 2016 | $210,000 | -8.7% | 17,800 | 0.0% | 0.00% | – |
| Q2 2016 | $230,000 | -19.3% | 17,800 | 0.0% | 0.00% | – |
| Q1 2016 | $285,000 | -48.5% | 17,800 | -7.8% | 0.00% | -100.0% |
| Q4 2015 | $553,000 | +11.0% | 19,300 | +10.3% | 0.00% | 0.0% |
| Q3 2015 | $498,000 | -34.6% | 17,500 | -17.5% | 0.00% | 0.0% |
| Q2 2015 | $762,000 | +30.5% | 21,200 | +110.9% | 0.00% | 0.0% |
| Q1 2015 | $584,000 | +40.7% | 10,050 | +2.0% | 0.00% | – |
| Q4 2014 | $415,000 | +19.6% | 9,850 | +10.1% | 0.00% | – |
| Q3 2014 | $347,000 | +23.9% | 8,950 | 0.0% | 0.00% | – |
| Q2 2014 | $280,000 | – | 8,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 5,406,844 | $52,014,000 | 0.66% |
| ETF MANAGERS GROUP, LLC | 282,268 | $3,255,000 | 0.24% |
| Mirae Asset Global Investments Co., Ltd. | 1,470,996 | $14,151,000 | 0.19% |
| Financial Gravity Companies, Inc. | 4,467 | $42,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 67,200 | $646,000 | 0.04% |
| TCI Wealth Advisors, Inc. | 7,766 | $75,000 | 0.03% |
| Freedom Investment Management, Inc. | 64,741 | $623,000 | 0.03% |
| GAM Holding AG | 83,940 | $808,000 | 0.02% |
| SFMG, LLC | 11,994 | $115,000 | 0.02% |
| SHELL ASSET MANAGEMENT CO | 95,127 | $915,000 | 0.02% |